Search

Marilyn G. Macasiano

Examiner (ID: 2397, Phone: (571)270-5205 , Office: P/3688 )

Most Active Art Unit
3688
Art Unit(s)
3688, 3622
Total Applications
654
Issued Applications
347
Pending Applications
61
Abandoned Applications
258

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18108053 [patent_doc_number] => 20230000933 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-01-05 [patent_title] => AGENT FOR PREVENTION OR REMEDIATION OF STRESS DISORDERS AND COMPOSITION CONTAINING SAME [patent_app_type] => utility [patent_app_number] => 17/782136 [patent_app_country] => US [patent_app_date] => 2020-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5029 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17782136 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/782136
AGENT FOR PREVENTION OR REMEDIATION OF STRESS DISORDERS AND COMPOSITION CONTAINING SAME Nov 25, 2020 Abandoned
Array ( [id] => 18110859 [patent_doc_number] => 20230003739 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-01-05 [patent_title] => OPTICAL METHOD FOR DETECTING A TARGET MOLECULE BY MEANS OF THE AMPLIFICATION IN THE INTERFERENCE RESPONSE, RESULTING FROM THE REFRACTIVE INDEX AND DISPERSION [patent_app_type] => utility [patent_app_number] => 17/781697 [patent_app_country] => US [patent_app_date] => 2020-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9993 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 238 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17781697 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/781697
OPTICAL METHOD FOR DETECTING A TARGET MOLECULE BY MEANS OF THE AMPLIFICATION IN THE INTERFERENCE RESPONSE, RESULTING FROM THE REFRACTIVE INDEX AND DISPERSION Nov 24, 2020 Pending
Array ( [id] => 18649355 [patent_doc_number] => 20230295152 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-21 [patent_title] => PYRIDOPYRIMIDINONE DERIVATIVES AS AHR ANTAGONISTS [patent_app_type] => utility [patent_app_number] => 17/756243 [patent_app_country] => US [patent_app_date] => 2020-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 46589 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17756243 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/756243
PYRIDOPYRIMIDINONE DERIVATIVES AS AHR ANTAGONISTS Nov 19, 2020 Pending
Array ( [id] => 17157269 [patent_doc_number] => 20210318320 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-14 [patent_title] => CALIBRATOR FOR IMMUNOASSAYS [patent_app_type] => utility [patent_app_number] => 16/952473 [patent_app_country] => US [patent_app_date] => 2020-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12669 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16952473 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/952473
CALIBRATOR FOR IMMUNOASSAYS Nov 18, 2020 Abandoned
Array ( [id] => 18056322 [patent_doc_number] => 20220387408 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-08 [patent_title] => USE OF MAST CELL STABILIZER FOR THE TREATMENT OF HEART FAILURE WITH PRESERVED EJECTION FRACTION [patent_app_type] => utility [patent_app_number] => 17/776075 [patent_app_country] => US [patent_app_date] => 2020-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4758 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17776075 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/776075
USE OF MAST CELL STABILIZER FOR THE TREATMENT OF HEART FAILURE WITH PRESERVED EJECTION FRACTION Nov 9, 2020 Abandoned
Array ( [id] => 18034708 [patent_doc_number] => 20220378923 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-01 [patent_title] => BET DEGRADER [patent_app_type] => utility [patent_app_number] => 17/764883 [patent_app_country] => US [patent_app_date] => 2020-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 114908 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 364 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17764883 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/764883
BET DEGRADER Sep 29, 2020 Pending
Array ( [id] => 17806307 [patent_doc_number] => 20220258142 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-18 [patent_title] => METALLOSILICATE CATALYST SOLVENT WASH [patent_app_type] => utility [patent_app_number] => 17/626156 [patent_app_country] => US [patent_app_date] => 2020-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5943 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17626156 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/626156
METALLOSILICATE CATALYST SOLVENT WASH Sep 28, 2020 Abandoned
Array ( [id] => 17961352 [patent_doc_number] => 20220341933 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-27 [patent_title] => A NOVEL COMPLEX FORMED BETWEEN THE FLAVIVIRAL NON-STRUCTURAL NS1 PROTEIN AND PLASMA LIPOPROTEINS [patent_app_type] => utility [patent_app_number] => 17/761767 [patent_app_country] => US [patent_app_date] => 2020-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10028 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17761767 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/761767
A NOVEL COMPLEX FORMED BETWEEN THE FLAVIVIRAL NON-STRUCTURAL NS1 PROTEIN AND PLASMA LIPOPROTEINS Sep 24, 2020 Pending
Array ( [id] => 18091375 [patent_doc_number] => 20220409716 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-29 [patent_title] => T-CELL COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME [patent_app_type] => utility [patent_app_number] => 17/763548 [patent_app_country] => US [patent_app_date] => 2020-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33054 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -25 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17763548 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/763548
T-CELL COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME Sep 23, 2020 Pending
Array ( [id] => 18523011 [patent_doc_number] => 20230233665 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-27 [patent_title] => ANTI- SARS-COV-2-INFECTION PROTEIN AND VACCINE [patent_app_type] => utility [patent_app_number] => 17/923303 [patent_app_country] => US [patent_app_date] => 2020-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7157 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17923303 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/923303
ANTI- SARS-COV-2-INFECTION PROTEIN AND VACCINE Sep 17, 2020 Pending
Array ( [id] => 18987689 [patent_doc_number] => 20240059658 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-02-22 [patent_title] => QUINOLINE DERIVATIVES AND USES IN MANAGING CANCER [patent_app_type] => utility [patent_app_number] => 17/642032 [patent_app_country] => US [patent_app_date] => 2020-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40284 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17642032 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/642032
QUINOLINE DERIVATIVES AND USES IN MANAGING CANCER Sep 9, 2020 Abandoned
Array ( [id] => 17896978 [patent_doc_number] => 20220306640 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-29 [patent_title] => HYDANTOIN DERIVATIVE [patent_app_type] => utility [patent_app_number] => 17/638375 [patent_app_country] => US [patent_app_date] => 2020-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 55164 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17638375 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/638375
HYDANTOIN DERIVATIVE Sep 3, 2020 Abandoned
Array ( [id] => 17837938 [patent_doc_number] => 20220275243 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-01 [patent_title] => SURFACE FUNCTIONALIZED SUBSTRATES AND METHODS OF MAKING THE SAME [patent_app_type] => utility [patent_app_number] => 17/635572 [patent_app_country] => US [patent_app_date] => 2020-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7130 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17635572 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/635572
SURFACE FUNCTIONALIZED SUBSTRATES AND METHODS OF MAKING THE SAME Aug 19, 2020 Pending
Array ( [id] => 17836414 [patent_doc_number] => 20220273719 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-01 [patent_title] => GENETICALLY MODIFIED NK CELLS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/632877 [patent_app_country] => US [patent_app_date] => 2020-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15693 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17632877 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/632877
GENETICALLY MODIFIED NK CELLS AND USES THEREOF Aug 10, 2020 Abandoned
Array ( [id] => 17837686 [patent_doc_number] => 20220274991 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-01 [patent_title] => SMALL MOLECULE INHIBITORS OF KU70/80 AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/626995 [patent_app_country] => US [patent_app_date] => 2020-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9953 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17626995 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/626995
SMALL MOLECULE INHIBITORS OF KU70/80 AND USES THEREOF Jul 15, 2020 Abandoned
Array ( [id] => 16569112 [patent_doc_number] => 20210008118 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-01-14 [patent_title] => METHOD FOR ENHANCING MIGRATION OF STEM CELLS INTO CANCER CELLS [patent_app_type] => utility [patent_app_number] => 16/926015 [patent_app_country] => US [patent_app_date] => 2020-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9199 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16926015 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/926015
METHOD FOR ENHANCING MIGRATION OF STEM CELLS INTO CANCER CELLS Jul 9, 2020 Pending
Array ( [id] => 17988893 [patent_doc_number] => 20220354930 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-11-10 [patent_title] => Hemoglobin Substitute Mixtures Including Reconstituted Plasma and Platelets and Their Manufacture and Use [patent_app_type] => utility [patent_app_number] => 17/623536 [patent_app_country] => US [patent_app_date] => 2020-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9218 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17623536 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/623536
Hemoglobin Substitute Mixtures Including Reconstituted Plasma and Platelets and Their Manufacture and Use Jul 1, 2020 Abandoned
Array ( [id] => 18055638 [patent_doc_number] => 20220386724 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-08 [patent_title] => ANTIMICROBIAL DYES FOR HEALTHCARE APPAREL [patent_app_type] => utility [patent_app_number] => 17/624154 [patent_app_country] => US [patent_app_date] => 2020-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3547 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17624154 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/624154
ANTIMICROBIAL DYES FOR HEALTHCARE APPAREL Jun 30, 2020 Abandoned
Array ( [id] => 18065687 [patent_doc_number] => 20220396774 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-15 [patent_title] => COMPOSITIONS AND METHODS FOR GENERATING INSULIN-PRODUCING BETA CELLS [patent_app_type] => utility [patent_app_number] => 17/622436 [patent_app_country] => US [patent_app_date] => 2020-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16053 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17622436 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/622436
COMPOSITIONS AND METHODS FOR GENERATING INSULIN-PRODUCING BETA CELLS Jun 30, 2020 Pending
Array ( [id] => 18707581 [patent_doc_number] => 20230330158 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-19 [patent_title] => INTESTINAL MICROBIOTA BACTERIA AND COMPOSITION CONTAINING SAME FOR USE IN THE PREVENTION AND/OR TREATMENT OF DISEASES CHARACTERISED BY EXCESS 2-HYDROXYGLUTARATE [patent_app_type] => utility [patent_app_number] => 17/915610 [patent_app_country] => US [patent_app_date] => 2020-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8793 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17915610 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/915610
INTESTINAL MICROBIOTA BACTERIA AND COMPOSITION CONTAINING SAME FOR USE IN THE PREVENTION AND/OR TREATMENT OF DISEASES CHARACTERISED BY EXCESS 2-HYDROXYGLUTARATE Jun 23, 2020 Abandoned
Menu